TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - QIAGEN Stock

Certificat

DE000CL02PW6

Real-time Boerse Frankfurt Warrants 07:23:25 2024-07-01 EDT
0.36 EUR 0.00% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - QIAGEN
Current month-32.08%
1 month-32.08%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-01 0.36 0.00%
24-06-28 0.36 -7.69%
24-06-27 0.39 +11.43%
24-06-26 0.35 -10.26%
24-06-25 0.39 -17.02%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 07:23 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying QIAGEN N.V.
IssuerLogo Issuer Société Générale Société Générale
WKN CL02PW
ISINDE000CL02PW6
Date issued 2020-01-24
Strike 34.52
Maturity Unlimited
Parity 10 : 1
Emission price 0.49
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.22
Lowest since issue 0.085
Spread 0.01
Spread %2.78%

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
41.09 USD
Average target price
50.37 USD
Spread / Average Target
+22.57%
Consensus